Add BrightSurf on Google Email

Low-frequency deep brain stimulation improves speech and swallowing after traumatic brain injury, Pitt study shows

A new University of Pittsburgh study found that low-frequency deep brain stimulation improves control of facial and tongue muscles involved in speaking and swallowing after traumatic brain injury. The treatment showed small but significant improvements in word intelligibility for one participant with TBI.

SourceUniversity of Pittsburgh·JournalNature Communications·DateAug 21, 2026

New experimental drug may restore movement after stroke

Researchers discovered that strokes cause a chain reaction within the brain, leading to neuronal cell death. They found that blocking collagen production can prevent this damage and even restore motor function in paralyzed monkeys. The new drug KDS12025 reduces hydrogen peroxide levels and prevents the entire process from being triggered.

SourceInstitute for Basic Science·JournalCell Metabolism·TypeExperimental study·DateApr 27, 2026

Medicare patients get different stroke care depending on plan, analysis reveals

A study by University of Virginia Health System researchers found that Medicare Advantage patients had better access to preventive care and rehabilitation after a stroke, leading to faster recovery times. In contrast, traditional Medicare patients were less likely to receive these services due to prior authorization requirements.

SourceUniversity of Virginia Health System·JournalJournal of Comparative Effectiveness Research·DateFeb 18, 2026

Brain tumor patients miss out on new treatments due to unequal access to tumor freezing and genetic testing, study warns

A recent UK study has highlighted the need for equitable investment and adoption of new innovations in brain tumor care. The research team found that genomic testing has expanded rapidly but many services are struggling to keep pace, leading to regional inequalities in access to advanced treatments.

SourceUniversity of Bristol·JournalNeuro-Oncology Practice·TypeData/statistical analysis·DateNov 12, 2025

Missing molecule may explain Down syndrome

Scientists found a promising candidate, pleiotrophin, which is essential for brain development and function; restoring it may improve brain circuits in individuals with Down syndrome and other neurological diseases. The study's findings suggest using modified viruses to deliver the protein directly into cells could lead to new treatments.

SourceUniversity of Virginia Health System·JournalCell Reports·DateOct 17, 2025

ALS appears to be an autoimmune disease

Researchers at La Jolla Institute for Immunology discovered that ALS is likely caused by an autoimmune reaction triggered by inflammatory CD4+ T cells targeting specific proteins in the nervous system. Anti-inflammatory CD4+ T cells may slow disease progression and prolong survival times.

SourceLa Jolla Institute for Immunology·JournalNature·TypeExperimental study·DateOct 1, 2025

Moderate-to-regular daily sleep patterns are associated with enhanced cognitive function

A new study published in Sleep Medicine found that daily sleep patterns have a significant impact on cognitive function. Researchers discovered that individuals with moderate-to-regular sleep patterns performed better in cognitive assessments than those with highly irregular or rigid sleep patterns.

Editing Parkinson's Disease – KAIST makes world's first discovery of an inflammatory RNA editing enzyme​

Researchers at KAIST have identified a key mechanism behind neuroinflammatory responses in Parkinson's disease, which is regulated by an RNA editing enzyme called ADAR1. This discovery suggests that targeting this enzyme could serve as a novel therapeutic strategy for treating the disease.

SourceThe Korea Advanced Institute of Science and Technology (KAIST)·JournalScience Advances·TypeExperimental study·DateMay 2, 2025

An unexpected insight into Alzheimer’s disease

A unique case study reveals an unexpected discrepancy between Alzheimer's pathology and cognitive function in a woman with Down syndrome. The study highlights the need to expand inclusion criteria for therapeutic drug trials and uncover genetic or lifestyle factors that contribute to cognitive preservation.

SourceUniversity of Pittsburgh·JournalAlzheimer s & Dementia·TypeCase study·DateFeb 28, 2025

New imaging study finds evidence that emotion regulation is not always the most effective strategy to mitigate suicidal ideation

Researchers found that individuals with depression who engage in reflexive emotion regulation experience increased suicidal thoughts during daily stressful events. In contrast, adaptive responses to stress were observed when participants used reappraisal strategy.

SourceElsevier·JournalBiological Psychiatry Cognitive Neuroscience and Neuroimaging·TypeImaging analysis·DateNov 25, 2024

Antisense oligonucleotide treatment shows promise in treating Parkinson's disease progression

Researchers from Tokyo Medical and Dental University demonstrate a proof of concept for antisense nucleic acid therapy to prevent the spread of α-synuclein pathologies in synucleinopathies. The treatment, involving antisense oligonucleotides, effectively reduces Lewy pathology-like neuronal inclusion by over 90%.

SourceTokyo Medical and Dental University·JournalActa Neuropathologica Communications·DateJul 25, 2024

Does COVID-19 affect Alzheimer’s disease risk?

A review in the Journal of Neurochemistry suggests a link between COVID-19 and Alzheimer's disease, with age being the largest contributing factor. Emerging evidence may further support this association, with research assessing influences on AD neuropathology.

SourceWiley·JournalJournal of Neurochemistry·DateOct 18, 2023

BU CTE Center publishes largest CTE case series ever in youth, high school and college athletes who died young

A new study published in JAMA Neurology found that over 40% of young contact and collision sport athletes have CTE, a degenerative brain disease caused by repetitive head impacts. The study also highlighted the importance of assessing symptoms and clinical presentation of CTE in living athletes.

SourceBoston University School of Medicine·JournalJAMA Neurology·TypeCase study·DateAug 28, 2023